Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MenoGeniX Inc.

Latest From MenoGeniX Inc.

MenoGeniX Inc.

MenoGeniX is developing a repurposed form of filgrastim as a non-hormonal treatment for menopausal symptoms, including hot flashes. Having achieved clinically meaningful results from its Phase 1b clinical trial, MenoGeniX’s goal is to find an industry partner or additional institutional investors to move the compound forward.

See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MenoGeniX Inc.
  • Senior Management
  • Debra Duke, Pres. & CEO
  • Contact Info
  • MenoGeniX Inc.
    Phone: (303) 995-7979
    12635 East Montview Blvd.
    Aurora, CO 80045